| |
| |
|
| Insider
Information: |
Walbert Timothy P |
| Relationship: |
Director |
| City: |
Waukegan |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
131,514 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,346,734 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
131,514 |
|
|
| Total
Value |
$3,346,734 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
Chairman, President an... |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
XOMA Corporation |
XOMA |
Director |
2016-07-21 |
129,314 |
2012-11-13 |
0 |
Premium* |
|
|
Egalet Corp |
EGLT |
Director |
2020-05-20 |
0 |
|
0 |
Premium* |
|
|
Sucampo Pharmaceuticals, Inc. |
SCMP |
Director |
2018-02-13 |
0 |
2016-06-02 |
0 |
Premium* |
|
|
Sagimet Biosciences Inc. |
SGMT |
Director |
2024-04-01 |
2,200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
160 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2022-05-31 |
4 |
AS |
$92.04 |
$2,311,980 |
D/D |
(25,000) |
435,549 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2022-06-03 |
4 |
OE |
$22.14 |
$553,500 |
D/D |
25,000 |
460,826 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2022-06-03 |
4 |
AS |
$92.08 |
$2,308,468 |
D/D |
(25,000) |
435,826 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2022-12-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,185 |
56,385 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2022-12-30 |
4 |
D |
$113.80 |
$765,760 |
I/I |
(6,729) |
49,656 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
104,498 |
540,324 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2023-01-01 |
4 |
D |
$113.80 |
$5,276,337 |
D/D |
(46,365) |
493,959 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2023-10-06 |
4 |
D |
$116.50 |
$71,853,938 |
D/D |
(616,772) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2023-10-06 |
4 |
D |
$116.50 |
$30,053,971 |
I/I |
(257,974) |
0 |
0 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2024-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,200 |
|
% |
|
160 Records found
|
|
Page 7 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
